Johnson & Johnson made the landmark announcement this week that it would ban harmful chemicals from their products. The company has already made the pledge to remove toxic chemicals from its baby products by 2013.

Jennifer Chelune, a spokeswoman for the Cincinnati-based company, declined to comment. Berkshire pared its holdings of Johnson & Johnson by about two-thirds to 10.3 million shares. The world's biggest health-products maker was ordered in April to pay ...

Johnson & Johnson is rumored to be considering the acquisition of a local baby-care product vendor Shanghai Elsker in China, a move that could strengthen its foothold in the rapidly-growing Chinese baby-care market.

The health regulator said certain lots of bone putty made by Johnson & Johnson unit Synthes were recalled as there was potential for the putty to catch fire if it came in contact with electrosurgical cautery systems during surgery.

Johnson & Johnson and Pfizer announced on Monday that they were halting development of a closely watched Alzheimer's drug after two clinical trials failed to show that it was effective in patients with mild to moderate forms of the disease.

Janssen Biotech will make an upfront payment of $55 million for the license and Johnson & Johnson Development Corp would invest 475 million Danish crowns ($80 million) in new Genmab shares, the company said.

Prompted by growing concerns raised by the Campaign for Safe Cosmetics, Johnson & Johnson makers of Aveeno, Neutrogena, and Johnson's Baby Shampoo, announced today that it will be removing carcinogens and other toxic chemicals from its baby ...

Johnson & Johnson announced Thursday that its pharmaceutical unit had reached a $181 million consumer fraud settlement with 36 states and the District of Columbia over its marketing of Risperdal, an antipsychotic drug.